| Product Includes | Product # | Quantity | Mol. Wt | Isotype/Source |
|---|---|---|---|---|
| Phospho-PAK1 (Ser144)/PAK2 (Ser141) Antibody | 2606 | 20 µl | 61 to 67 (PAK2), 68 to 74 (PAK1/3) kDa | Rabbit |
| Phospho-PAK1 (Ser199/204)/PAK2 (Ser192/197) Antibody | 2605 | 20 µl | 61 to 67 (PAK2), 68 to 74 (PAK1/3) kDa | Rabbit |
| Phospho-PAK1 (Thr423)/PAK2 (Thr402) Antibody | 2601 | 20 µl | 61 to 67 (PAK2), 68 to 74 (PAK1/3) kDa | Rabbit |
| Phospho-PAK2 (Ser20) Antibody | 2607 | 20 µl | 61 to 67 kDa | Rabbit |
| PAK1 Antibody | 2602 | 20 µl | 68 kDa | Rabbit |
| PAK2 (C17A10) Rabbit mAb | 2615 | 20 µl | 61 kDa | Rabbit IgG |
| PAK3 Antibody | 2609 | 20 µl | 65 kDa | Rabbit |
| PAK1/2/3 Antibody | 2604 | 20 µl | 61 (PAK2), 68 (PAK1/3) kDa | Rabbit |
| Anti-rabbit IgG, HRP-linked Antibody | 7074 | 100 µl | Goat |
Please visit cellsignal.com for individual component applications, species cross-reactivity, dilutions, protocols, and additional product information.
Description
The PAK antibody sampler kit provides and economical means to evaluate the activation status of PAK1, 2, and 3. This kit includes enough primary and secondary antibodies to perform two western blots with each antibody.
Storage
Background
The p21-activated kinase (PAK) family of serine/threonine kinases is engaged in multiple cellular processes, including cytoskeletal reorganization, MAPK signaling, apoptotic signaling, control of phagocyte NADPH oxidase and growth factor-induced neurite outgrowth (1,2). Several mechanisms that induce PAK activity have been reported. Binding of Rac/cdc42 to the CRIB (or PBD) domain near the amino terminus of PAK causes autophosphorylation and conformational changes in PAK (1). Phosphorylation of PAK1 at Thr423 by PDK induces activation of PAK1 (3). Several autophosphorylation sites have been identified, including serines 199 and 204 of PAK1 and serines 192 and 197 of PAK2 (4,5). Because the autophosphorylation sites are located in the amino-terminal inhibitory domain, it has been hypothesized that modification in this region prevents the kinase from reverting to an inactive conformation (6). Research indicates that phosphorylation of Ser144 of PAK1 or Ser139 of PAK3 (located in the kinase inhibitory domain) affects kinase activity (7). Phosphorylation of Ser21 of PAK1 or Ser20 of PAK2 regulates binding with the adaptor protein Nck (8).
- Knaus, U.G. and Bokoch, G.M. (1998) Int J Biochem Cell Biol 30, 857-62.
- Daniels, R.H. et al. (1998) EMBO J 17, 754-64.
- King, C.C. et al. (2000) J Biol Chem 275, 41201-9.
- Manser, E. et al. (1997) Mol Cell Biol 17, 1129-43.
- Gatti, A. et al. (1999) J Biol Chem 274, 8022-8.
- Lei, M. et al. (2000) Cell 102, 387-97.
- Chong, C. et al. (2001) J Biol Chem 276, 17347-53.
- Zhao, Z.S. et al. (2000) Mol Cell Biol 20, 3906-17.
Background References
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.
